AUD 0.8
(2.56%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 | 22.29 Thousand AUD | -49.19% |
2023 | 43.87 Thousand AUD | 0.0% |
2022 | - AUD | 0.0% |
2021 | - AUD | -100.0% |
2020 | 44.39 Thousand AUD | 0.0% |
2019 | - AUD | -100.0% |
2018 | 377.8 Thousand AUD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q3 | - AUD | -100.0% |
2024 Q2 | 22.29 Thousand AUD | 0.0% |
2024 Q4 | 22.29 Thousand AUD | 0.0% |
2024 FY | 22.29 Thousand AUD | -49.19% |
2024 Q1 | - AUD | -100.0% |
2023 Q1 | - AUD | 0.0% |
2023 Q2 | - AUD | 0.0% |
2023 FY | 43.87 Thousand AUD | 0.0% |
2023 Q4 | 43.87 Thousand AUD | 0.0% |
2023 Q3 | - AUD | 0.0% |
2022 Q1 | - AUD | 0.0% |
2022 Q4 | - AUD | 0.0% |
2022 FY | - AUD | 0.0% |
2022 Q3 | - AUD | 0.0% |
2022 Q2 | - AUD | 0.0% |
2021 Q1 | - AUD | -100.0% |
2021 FY | - AUD | -100.0% |
2021 Q4 | - AUD | 0.0% |
2021 Q3 | - AUD | -100.0% |
2021 Q2 | 25.83 Thousand AUD | 0.0% |
2020 FY | 44.39 Thousand AUD | 0.0% |
2020 Q4 | 674.39 Thousand AUD | 5.13% |
2020 Q3 | 641.51 Thousand AUD | 0.0% |
2020 Q1 | - AUD | 0.0% |
2019 FY | - AUD | -100.0% |
2018 FY | 377.8 Thousand AUD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Althea Group Holdings Limited | 972 Thousand AUD | 97.707% |
Cann Group Limited | 72.46 Million AUD | 99.969% |
ECS Botanics Holdings Ltd | 1.02 Million AUD | 97.823% |
Ecofibre Limited | 25.49 Million AUD | 99.913% |
Elixinol Wellness Limited | 1.26 Million AUD | 98.234% |
Hygrovest Limited | - AUD | -Infinity% |
IDT Australia Limited | 4.46 Million AUD | 99.501% |
Invion Limited | - AUD | -Infinity% |
Little Green Pharma Ltd | 11.86 Million AUD | 99.812% |
Medical Developments International Limited | 2.28 Million AUD | 99.025% |
Vitura Health Limited | 5.31 Million AUD | 99.581% |
Vita Life Sciences Limited | 387 Thousand AUD | 94.24% |